Prelude Therapeutics Incorporated

8-K Shareholder vote results Jun 10, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2026 8-K Entered a material agreement; Other events Apr 21, 2026 8-K Regulation FD disclosure; Other events Apr 20, 2026 8-K Director or officer change Apr 15, 2026 8-K Other events Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Mar 10, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 10, 2026 8-K Regulation FD disclosure Feb 3, 2026 8-K Regulation FD disclosure Jan 9, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 12, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Nov 4, 2025 8-K Director or officer change; Regulation FD disclosure Oct 17, 2025 8-K Other events Sep 19, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 8-K Director or officer change; Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2025 8-K Other events Apr 25, 2025 8-K Delisting notice or listing-rule failure Mar 28, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 10, 2025 8-K Director or officer change Feb 5, 2025 8-K Other events Dec 11, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 6, 2024 8-K Other events Oct 24, 2024 8-K Other events Sep 13, 2024 8-K Regulation FD disclosure Sep 9, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 12, 2024 8-K Shareholder vote results Jun 18, 2024 8-K Regulation FD disclosure Jun 12, 2024 8-K/A Director or officer change May 16, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Director or officer change Apr 10, 2024